The Role of Tumor-Associated Neutrophils in Colorectal Cancer
- PMID: 30691207
- PMCID: PMC6386937
- DOI: 10.3390/ijms20030529
The Role of Tumor-Associated Neutrophils in Colorectal Cancer
Abstract
Colorectal cancer (CRC) is one of the most common causes of cancer deaths worldwide and the number of CRC patients is increasing progressively. Despite the improvement of the surgical techniques and chemotherapy, we have not completely overcome this disease yet due to the metastases. Therefore, understanding the mechanisms through which metastasis occurs is important for overcoming CRC. Normal host cells in the tumor microenvironment, such as macrophages and fibroblasts, have been reported to promote the growth of CRCs. Although neutrophils were originally considered to have defensive functions against tumor cells, it has been revealed that some populations of neutrophils, called as tumor-associated neutrophils (TANs), have tumor-supportive functions. The plasticity between tumor-suppressive and -supportive neutrophils are regulated by transforming growth factor (TGF)-β and Interferon-β signaling. Some studies have demonstrated that TANs promote the spread of cancer cells to distant organs. TANs contribute to the tumor invasion and angiogenesis through the production of matrix metalloproteinase-9 (MMP9), vascular endothelial growth factor (VEGF), and hepatocyte growth factor (HGF) in the primary and metastatic sites. Neutrophils also promotes tumor cell dissemination by capturing circulating tumor cells using neutrophil extracellular traps and promote their migration to distant sites. The neutrophil-to-lymphocyte ratio is a well-defined predictive marker for CRC patients. In this review, we highlight the molecular signaling between TANs and CRC cells and the possibility of TANs as a potential target for cancer therapy.
Keywords: cancer immunity; colon cancer; neutrophils; tumor microenvironment.
Conflict of interest statement
No potential conflict of interest exist.
Figures
Similar articles
-
Role of tumor-associated neutrophils in regulation of tumor growth in lung cancer development: A mathematical model.PLoS One. 2019 Jan 28;14(1):e0211041. doi: 10.1371/journal.pone.0211041. eCollection 2019. PLoS One. 2019. PMID: 30689655 Free PMC article.
-
Tissue-infiltrating neutrophils constitute the major in vivo source of angiogenesis-inducing MMP-9 in the tumor microenvironment.Neoplasia. 2014 Oct 23;16(10):771-88. doi: 10.1016/j.neo.2014.08.013. eCollection 2014 Oct. Neoplasia. 2014. PMID: 25379015 Free PMC article.
-
Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.Gut. 2022 Dec;71(12):2489-2501. doi: 10.1136/gutjnl-2021-325137. Epub 2022 Jan 27. Gut. 2022. PMID: 35086885
-
Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.Int J Mol Sci. 2019 Nov 20;20(23):5822. doi: 10.3390/ijms20235822. Int J Mol Sci. 2019. PMID: 31756952 Free PMC article. Review.
-
Cancer-promoting mechanisms of tumor-associated neutrophils.Am J Surg. 2017 Nov;214(5):938-944. doi: 10.1016/j.amjsurg.2017.08.003. Epub 2017 Aug 10. Am J Surg. 2017. PMID: 28830617 Review.
Cited by
-
Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer.J Clin Pathol. 2021 Oct;74(10):625-634. doi: 10.1136/jclinpath-2020-207309. Epub 2021 Mar 22. J Clin Pathol. 2021. PMID: 33753562 Free PMC article. Review.
-
Association of circulating tumor cell-white blood cell clusters with survival outcomes in patients with colorectal cancer after curative intent surgery.BMC Gastroenterol. 2022 Dec 6;22(1):503. doi: 10.1186/s12876-022-02603-4. BMC Gastroenterol. 2022. PMID: 36474175 Free PMC article.
-
A novel neutrophil extracellular traps-related lncRNA signature predicts prognosis in patients with early-stage lung adenocarcinoma.Ann Med. 2023;55(2):2279754. doi: 10.1080/07853890.2023.2279754. Epub 2023 Nov 19. Ann Med. 2023. PMID: 37980632 Free PMC article.
-
Prognostic significance of serum Chemerin and neutrophils levels in patients with oral squamous cell carcinoma.Heliyon. 2024 Jun 10;10(12):e32393. doi: 10.1016/j.heliyon.2024.e32393. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 38975159 Free PMC article.
-
The combination of pre-neoadjuvant chemoradiotherapy inflammation biomarkers could be a prognostic marker for rectal cancer patients.Sci Rep. 2022 Mar 11;12(1):4286. doi: 10.1038/s41598-022-07726-y. Sci Rep. 2022. PMID: 35277532 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous